MoneyWorks4Me

The Sales for the quarter ended September 2024 of Rs. 2435.92 millions rose by 48.90% from Rs. 1635.96 millions.The Total Profit for the quarter ended September 2024 of Rs. 376.78 millions grew from Rs.-209.56 millionsOperating profit for the quarter ended September 2024 rose to 567.09 millions as compared to 198.82 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 2435.92 1635.96 48.90 4147.29 3059.47 35.56 6875.83 6167.34 11.49
Other Income 85.78 12.59 581.33 104.75 23.61 343.67 137.86 43.20 219.12
PBIDT 567.09 198.82 185.23 849.05 463.45 83.20 1214.53 1269.82 -4.35
Interest 4.94 7.73 -36.09 48.67 12.82 279.64 58.94 24.14 144.16
PBDT 562.15 -126.45 -544.56 800.38 133.09 501.38 838.05 1245.68 -32.72
Depreciation 61.96 34.03 82.07 118.17 68.28 73.07 146.94 123.42 19.06
PBT 500.19 -160.48 -411.68 682.21 64.81 952.63 691.11 1122.26 -38.42
TAX 123.41 49.08 151.45 168.26 105.77 59.08 254.25 288.82 -11.97
Deferred Tax 4.89 6.54 -25.23 13.56 9.85 37.66 45.12 25.05 80.12
PAT 376.78 -209.56 -279.80 513.95 -40.96 -1354.76 436.86 833.44 -47.58
Equity 409.28 368.81 10.97 409.28 368.81 10.97 368.81 364.37 1.22
PBIDTM(%) 23.28 12.15 91.56 20.47 15.15 35.15 17.66 20.59 -14.21
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..